Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (9): 1040-1043.

Previous Articles     Next Articles

Determination of the median effective dose of rocuronium via tracheal in tubation in different age male patients by sequential experimental method

ZHANG Kai, YUE Xiu-qin   

  1. First Affiliated Hospital, Xinxiang Medical University, Xinxiang 453100, Henan, China
  • Received:2009-06-25 Revised:2009-09-20 Published:2020-11-03

Abstract: AIM: To determinate the median effective dose (IED50) of rocuronium via tracheal intubation in different ages male patients by sequential experimental method, and study the effect of the age to IED50. METHODS: 40 patients(ASA grade Ⅰ or Ⅱ) scheduled for selective surgical procedure under general anaesthesia were studied. The patients were divided into two groups, young men group(n =20) and older men group(n =20). The tracheal intubation dose was divided into four grades by geometric progression growth, 0.35, 0.42, 0.5, 0.6 mg/kg in the young men group and 0.31, 0.37, 0.44 and 0.53 mg/kg in the older men group. The IED50 and 95 % confidence interval (95 %CI) of rocuronium during intubation in either group was determined by sequential experimental method. RESULTS: IED50 was 0.4502 mg/kg in the young men group, which was 0.4039 mg/kg in the older men group. The IED50 in the older women group was 89.7 % of that in the young women group(P <0.05). The concentration of plasma total protein and albumin in the oldermen group was lower than that in the young men group (P <0.05). CONCLUSION: Sequential experimential method is a simple, efficient and reliable method for the IED50 determination of rocuronium during intubation. The IED50 was lower in the older men group than that in the young men group, which is possibly related to the difference of the concentration of plasma total protein in different ages male patients.

Key words: androstanols, sequential experimental method, median effective dose, age

CLC Number: